Onno van de Stolpe

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Onno van de Stolpe (born 25 October 1959, Geldrop[1]) is a Dutch businessman and is currently the CEO of Galapagos NV, a drug discovery and development company.


He obtained an MSc degree from the Agricultural University in Wageningen (the Netherlands).


Mr. Van de Stolpe founded Galapagos NV in 1999 while he was Managing Director Genomics at Introgene (now Crucell). Prior to joining Introgene in 1998, he was Managing Director of Molecular Probes Europe. He established this European headquarters after joining Molecular Probes in the US. Previously, he worked for the Netherlands Foreign Investment Agency in California, where he was responsible for recruiting biotech and medical device companies to locate in the Netherlands. Mr. Van de Stolpe started his career as Manager Business Development at MOGEN in Leiden.